TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11057934

Group type: EXPERIMENTAL
Intervention: Intravenous hydration
Number of subjects: 81

Group type: COMPARATOR
Intervention: Oral hydration
Number of subjects: 81
Study: 9031445

Group type: EXPERIMENTAL
Intervention: Ardeparin 50 anti-Xa U/kg s.c. BID
Number of subjects: 860

Group type: COMPARATOR
Intervention: Warfarin (adjusted-dose, INR 2.0 to 3.0)
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: Ardeparin 25 anti-Xa U/kg s.c. BID
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: Ardeparin 35 anti-Xa U/kg s.c. BID
Number of subjects: 860

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 860
Study: 8295037

Group type: EXPERIMENTAL
Intervention: Relaxation training (n = 25, 15-minute daily program at the workplace for 6 months)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (n = 25, not specified)
Number of subjects: 50
Study: 3554702

Group type: EXPERIMENTAL
Intervention: Piperacillin (12 Gm/day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Cefamandole (6 Gm/day)
Number of subjects: 72
Study: 31749047

Group type: EXPERIMENTAL
Intervention: Navilas laser (OD-OS, 577 nm)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional multispot laser (Quantel Medical, 577 nm)
Number of subjects: 16
Study: 30138685

Group type: EXPERIMENTAL
Intervention: Midodrine (15–30 mg/day) and albumin (40 g/15 days)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Midodrine and albumin
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 28256022

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG probiotic enteric regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 25124829

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance and therapist adherence in successful treatments
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance and therapist adherence in treatment failure
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Therapists' competence
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Therapists' adherence and competence
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance within one session
Number of subjects: 61
Study: 23968628

Group type: EXPERIMENTAL
Intervention: Plain packaging (two plainest packages)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Non-smokers
Number of subjects: 220

Group type: COMPARATOR
Intervention: Original package
Number of subjects: 220

Group type: COMPARATOR
Intervention: Smokers
Number of subjects: 220
Study: 21625533

Group type: EXPERIMENTAL
Intervention: Oxygen supplementation via nasal cannulae for 72 hours
Number of subjects: 289

Group type: COMPARATOR
Intervention: Control (room air, oxygen given only if clinically indicated)
Number of subjects: 289
Study: 19102857

Group type: EXPERIMENTAL
Intervention: Admission plasma B-type natriuretic peptide (BNP)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Pulmonary capillary wedge pressure (PCWP)
Number of subjects: 134
Study: 16492320

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% 40 mL injected when nerve stimulation elicited a distal motor response
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ropivacaine 0.75% 30 mL injected (7 mL to musculocutaneous nerve and 23 mL to median, ulnar or radial nerves)
Number of subjects: 50
Study: 14613361

Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Almotriptan 12.5 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Frovatriptan 2.5 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 5 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Naratriptan 2.5 mg
Number of subjects: 27
Study: 10857893

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) administered when monocytopenia (<150/microl) appeared on days 6 to 8 after chemotherapy (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Granulocyte colony-stimulating factor (G-CSF) administered when neutropenia (<1,000/microl) or leukopenia (<2,000/microl) appeared after chemotherapy (group B)
Number of subjects: 60
Study: 9086691

Group type: EXPERIMENTAL
Intervention: Group-based exercise (3 supervised sessions/week for 26 weeks, then 2 sessions/week)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Home-based exercise (30 min/day, 5 days/week, all exercise in home environment)
Number of subjects: 49
Study: 8227484

Group type: EXPERIMENTAL
Intervention: Iodinated glycerol (60 mg four times daily; n = 16)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 29
Study: 30835643

Group type: EXPERIMENTAL
Intervention: Brief Cognitive Behavioral Therapy (BCBT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Drug education (Control)
Number of subjects: 120
Study: 29934099

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg thrice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 27194199

Group type: EXPERIMENTAL
Intervention: Hydrocodone ER (15-90 mg every 12 hours)
Number of subjects: 182
Study: 24686105

Group type: EXPERIMENTAL
Intervention: Website advertising
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Poster advertising
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Web-based advertising
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mental health worker referrals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Advertising online, via posters, and on a local radio station
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saturation advertising across many sources
Number of subjects: 0
Study: 22538330

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 1794

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1794
Study: 20109340

Group type: EXPERIMENTAL
Intervention: TC regimen (docetaxel plus carboplatin)
Number of subjects: 58

Group type: COMPARATOR
Intervention: FC regimen (5-fluorouracil plus carboplatin)
Number of subjects: 58
Study: 18037355

Group type: EXPERIMENTAL
Intervention: Behavioral videotape
Number of subjects: 138

Group type: COMPARATOR
Intervention: Standard instructional videotape
Number of subjects: 138
Study: 15828970

Group type: EXPERIMENTAL
Intervention: Translation preceding disorientation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disorientation preceding translation
Number of subjects: 0
Study: 12523448

Group type: EXPERIMENTAL
Intervention: Participants told that the civilian car crashed
Number of subjects: 2

Group type: COMPARATOR
Intervention: Participants not told that the civilian car crashed
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Participants told that the police car crashed
Number of subjects: 2

Group type: COMPARATOR
Intervention: Participants not told that the police car crashed
Number of subjects: 2
Study: 10618944

Group type: EXPERIMENTAL
Intervention: succinylcholine 0.5 mg kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: succinylcholine 0.25 mg kg‐1
Number of subjects: 60

Group type: COMPARATOR
Intervention: normal saline
Number of subjects: 60
Study: 7546679

Group type: EXPERIMENTAL
Intervention: 1000 mg amoxicillin every 12 h for 10 days
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 500 mg amoxicillin every 8 h for 10 days
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 1000 mg amoxicillin at 12 h before surgery
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 1000 mg amoxicillin at 8 h before surgery
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 1000 mg amoxicillin at 6 h before surgery
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: All treatment groups (acute and chronic sinusitis)
Number of subjects: 59
Study: 2020925

Group type: EXPERIMENTAL
Intervention: Intravenous administration of calcitonin 0.5 mg by intradermic route
Number of subjects: 6

Group type: COMPARATOR
Intervention: Subcutaneous administration of calcitonin 0.5 mg
Number of subjects: 6
Study: 7340377

Group type: EXPERIMENTAL
Intervention: 5 mg of morphine in 10 ml of saline (n = 15)
Number of subjects: 42

Group type: COMPARATOR
Intervention: 6‐8 ml of 0.5% bupivacaine with epinephrine (n = 17)
Number of subjects: 42

Group type: COMPARATOR
Intervention: 4‐6 ml of 0.5% bupivacaine with epinephrine
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 5 mg of morphine in 10 ml of saline
Number of subjects: 42
Study: 30142092

Group type: EXPERIMENTAL
Intervention: Progressive reducing assistance force group (n = 15)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Full assistance force group (n = 14)
Number of subjects: 29
Study: 28779933

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT‐i)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Auricular Acupuncture (AA)
Number of subjects: 60
Study: 25997550

Group type: EXPERIMENTAL
Intervention: Generic sildenafil 50 mg film-coated tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Viagra® 50 mg film-coated tablets (reference)
Number of subjects: 0
Study: 23252455

Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: No periodontal treatment (Control)
Number of subjects: 120
Study: 21371754

Group type: EXPERIMENTAL
Intervention: Mother Infant Transaction Program
Number of subjects: 93
Study: 19138577

Group type: EXPERIMENTAL
Intervention: Triple therapy (amoxicillin, metronidazole, and omeprazole)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Omeprazole alone (Control)
Number of subjects: 83
Study: 17380806

Group type: EXPERIMENTAL
Intervention: Home Illuminé 15% for 8 hours per day, over 7 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Home Illuminé 15% for 8 hours per day, over 14 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Home Illuminé 15% for 8 hours per day, over 28 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Home Illuminé 15% for 8 hours per day, over 42 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whitestrips for 30 minutes each time, for 14 times
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whitestrips for 30 minutes each time, for 28 times
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whitestrips for 30 minutes each time, for 42 times
Number of subjects: 24

Group type: COMPARATOR
Intervention: Unbleached specimens
Number of subjects: 24
Study: 15479657

Group type: EXPERIMENTAL
Intervention: Breastfeeding peer counseling (PC)
Number of subjects: 0
Study: 11133629

Group type: EXPERIMENTAL
Intervention: Tramadol 0.25%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lidocaine 0.5%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tramadol-Lidocaine 0.5%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sodium chloride 0.9% (saline)
Number of subjects: 60
Study: 9036907

Group type: EXPERIMENTAL
Intervention: New EMG biofeedback traction modality
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional cervical traction
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy subjects (conventional cervical traction)
Number of subjects: 24
Study: 7842998

Group type: EXPERIMENTAL
Intervention: 0.25% Clonidine HCl
Number of subjects: 269

Group type: COMPARATOR
Intervention: Control group (no Clonidine)
Number of subjects: 269
Study: 3276187

Group type: EXPERIMENTAL
Intervention: Cefoperazone
Number of subjects: 113
Study: 29366911

Group type: EXPERIMENTAL
Intervention: Telephone symptom management (TSM) intervention
Number of subjects: 51
Study: 28821530

Group type: EXPERIMENTAL
Intervention: WHISPER (sexual and reproductive health SMS intervention)
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: SHOUT (nutrition SMS intervention)
Number of subjects: 860

Group type: COMPARATOR
Intervention: Control group (equal-attention control for both WHISPER and SHOUT)
Number of subjects: 860
Study: 26298718

Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide implant
Number of subjects: 255

Group type: COMPARATOR
Intervention: Systemic therapy
Number of subjects: 255
Study: 24565457

Group type: EXPERIMENTAL
Intervention: AAAAI‐AWC intervention group
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study: 22004229

Group type: EXPERIMENTAL
Intervention: 500 IU 1,25 dihydroxy vitamin D3 + calcium combination
Number of subjects: 121

Group type: COMPARATOR
Intervention: Triple DMARD therapy + calcium alone
Number of subjects: 121
Study: 19057103

Group type: EXPERIMENTAL
Intervention: Cognitive group (balance exercise considering cognitive function; task difficulty, internal observation)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (balance exercise)
Number of subjects: 23
Study: 16980380

Group type: EXPERIMENTAL
Intervention: Ramipril (up to 15 mg per day)
Number of subjects: 5269

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5269
Study: 12622322

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 828

Group type: EXPERIMENTAL
Intervention: Lercanidipine
Number of subjects: 828

Group type: EXPERIMENTAL
Intervention: Lacidipine
Number of subjects: 828
Study: 10397291

Group type: EXPERIMENTAL
Intervention: Serum sialic acid in alcoholics
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Saliva sialic acid in alcoholics
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Sialic acid concentrations after 5 weeks of treatment
Number of subjects: 125

Group type: COMPARATOR
Intervention: Traditional markers of alcohol abuse
Number of subjects: 125
Study: 8862204

Group type: EXPERIMENTAL
Intervention: Pamidronate (i.v. formulation given monthly)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etidronate disodium, pamidronate disodium, clodronate disodium, alendronate sodium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral formulations of bisphosphonates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bisphosphonates in general
Number of subjects: 0
Study: 2057277

Group type: EXPERIMENTAL
Intervention: Surfactant treatment (surfactant TA containing surfactant proteins B and C, no SP-A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no surfactant treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surfactant treatment (surfactant TA)
Number of subjects: 0
Study: 6337763

Group type: EXPERIMENTAL
Intervention: Activated charcoal (140 gm) in divided doses over 12 hr
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 6
Study: 30260821

Group type: EXPERIMENTAL
Intervention: Immediate implant placement with anorganic bovine bone and resorbable collagen barrier (Group A)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Immediate implant placement without bone graft (Group B)
Number of subjects: 102
Study: 27716132

Group type: EXPERIMENTAL
Intervention: Financial incentive vouchers (€50 at end of training, €50 after 3 months, €50 after 6 months, €200 after 1 year)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No additional incentive (control group)
Number of subjects: 0
Study: 24737541

Group type: EXPERIMENTAL
Intervention: Cisplatin-based N-RCT
Number of subjects: 77

Group type: COMPARATOR
Intervention: Oxaliplatin-based N-RCT
Number of subjects: 77
Study: 23355182

Group type: EXPERIMENTAL
Intervention: Qigong intervention (5 weekly classes over 5 or 6 weeks of radiotherapy)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 96
Study: 20100393

Group type: EXPERIMENTAL
Intervention: Collectivism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individualism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collectivism and Individualism (chronic and primed)
Number of subjects: 0
Study: 18808446

Group type: EXPERIMENTAL
Intervention: Oral delayed-release mesalazine (2.4 g/day and 4.8 g/day)
Number of subjects: 687
Study: 15546963

Group type: COMPARATOR
Intervention: Standing Extended View (SEV)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Semiflexed, postero-anterior view (MTP)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Comparison of SEV and MTP views for osteophyte grading
Number of subjects: 47
Study: 12545143

Group type: EXPERIMENTAL
Intervention: Dipyridamole (300 mg/d for 3 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 12
Study: 11014886

Group type: EXPERIMENTAL
Intervention: Intraoral appliance therapy (ISMAR)
Number of subjects: 20
Study: 8638029

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other antiarrhythmic drugs
Number of subjects: 0
Study: 1592952

Group type: EXPERIMENTAL
Intervention: Drugs (specific drugs not mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized measure of benefit/harm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized, N‐of‐1 trial
Number of subjects: 0
Study: 2581099

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Albumin (ALB)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution (LRS)
Number of subjects: 83
Study: 30442510

Group type: EXPERIMENTAL
Intervention: Classroom education (25-45 minutes practice-while-watching session)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kiosk education (4-minute on-screen feedback and practice session)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Video-only education (1-minute video viewing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as video-only)
Number of subjects: 0
Study: 30185972

Group type: EXPERIMENTAL
Intervention: Specific DNA aptamers against dabigatran etexilate
Number of subjects: 0
Study: 27104984

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) lozenges, 2 per day for 3 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo lozenges, 2 per day for 3 weeks
Number of subjects: 47
Study: 25180378

Group type: EXPERIMENTAL
Intervention: Cranberry capsules (taken twice daily for 12 months)
Number of subjects: 928

Group type: COMPARATOR
Intervention: Placebo capsules (taken twice daily for 12 months)
Number of subjects: 928
Study: 23625628

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 46
Study: 20379187

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 0
Study: 19100010

Group type: EXPERIMENTAL
Intervention: Pericardial effusion (PE)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Left ventricular diastolic dysfunction (LVDD)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Pulmonary artery hypertension (PAH)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Left atrium enlargement
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Mitral insufficiency
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Aortic dilation
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Tricuspid insufficiency
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Left ventricular enlargement
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Left ventricular systolic dysfunction
Number of subjects: 124

Group type: COMPARATOR
Intervention: C reactive protein level (CRP)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Age
Number of subjects: 124

Group type: COMPARATOR
Intervention: Gammaglobulin level
Number of subjects: 124
Study: 16371736

Group type: EXPERIMENTAL
Intervention: Hypertonic saline plus dextran (HSD)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 27
Study: 14693066

Group type: EXPERIMENTAL
Intervention: L-OHP + LV + 5-FU + VP-16 (treatment group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: DDP + LV + 5-FU + VP-16 (control group)
Number of subjects: 48
Study: 11200144

Group type: EXPERIMENTAL
Intervention: Infusional fluorouracil (5-FU) in combination with cisplatin (Platinol) or newer agents docetaxel (Taxotere) and irinotecan (Camptosar)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primary chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preoperative treatment
Number of subjects: 0
Study: 8774625

Group type: EXPERIMENTAL
Intervention: Probucol (750 mg/day) for at least 30 days prior to PTCA (group P‐1)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Probucol (750 mg/day) for less than 14 days prior to PTCA (group P‐2)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Pravastatin (10 mg/day) for at least 30 days prior to PTCA (group V‐1)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Pravastatin (10 mg/day) for less than 14 days prior to PTCA (group V‐2)
Number of subjects: 141
Study: 1616359

Group type: EXPERIMENTAL
Intervention: Metronidazole (400 mg twice daily for weeks 0-8, then 400 mg three times a day for weeks 9-24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 2865187

Group type: EXPERIMENTAL
Intervention: Standard-dose oral contraceptive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive
Number of subjects: 0
Study: 30029967

Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Rupatadine 20 mg
Number of subjects: 277

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 277
Study: 29504705

Group type: EXPERIMENTAL
Intervention: Paclical (Arm A, n = 260)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Taxol® (Arm B, n = 265)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: All patients (n = 525)
Number of subjects: 525
Study: 27779454

Group type: EXPERIMENTAL
Intervention: Lercanidipine hydrochloride 10 mg/d
Number of subjects: 186

Group type: COMPARATOR
Intervention: Felodipine sustained-release tablets 5 mg/d
Number of subjects: 186

Group type: COMPARATOR
Intervention: Comparison between Lercanidipine and Felodipine
Number of subjects: 186
Study: 25307297

Group type: EXPERIMENTAL
Intervention: Recurrent stroke
Number of subjects: 5104

Group type: COMPARATOR
Intervention: No recurrent stroke
Number of subjects: 5104

Group type: EXPERIMENTAL
Intervention: Poor HRQOL
Number of subjects: 5104

Group type: COMPARATOR
Intervention: Good HRQOL
Number of subjects: 5104